Testing a PET scan for aldosterone and cortisol condition
Part of Hormones & metabolism clinical trials.
This trial tests whether a special PET/CT scan (68Ga-Pentixafor) can accurately identify the subtype of primary aldosteronism in people who also have excess cortisol. It may help determine if surgery is the right treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with primary aldosteronism (a condition causing high blood pressure from too much aldosterone).
- You also have autonomous cortisol secretion (too much cortisol, often seen after a 1 mg dexamethasone suppression test).
- You are willing to have surgery to remove the affected adrenal gland.
- Your adrenal CT or MRI scan shows a nodule (lump) that is at least 1 cm in size.
- You are not under 35 with low potassium, a large nodule, and very high aldosterone levels (which would allow bypassing a more invasive test).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special imaging scan (PET/CT) to help doctors identify adrenal tumors that produce too much of two hormones: aldosterone and cortisol. If you have both hormone imbalances confirmed by blood tests and are planning surgery to remove your adrenal gland, this scan may help your doctors see exactly where the tumor is.
This trial tests a special PET scan (68Ga-Pentixafor) to see if it can replace a more invasive blood test (AVS) for finding which adrenal gland is causing high blood pressure and high cortisol levels. It may help patients avoid a complicated procedure.
This study compares a newer, less invasive PET/CT scan (using 68Ga-Pentixafor) to the standard adrenal vein sampling test to identify which adrenal gland is causing high blood pressure in people with primary aldosteronism. If you're considering surgery to remove a nodule on your adrenal gland, this trial may help determine the best approach.
This trial compares different ways of doing adrenal vein sampling (a test to find which adrenal gland is causing high blood pressure). It aims to see if combining methods works better than using just one for people with primary aldosteronism.
This trial tests a special PET scan (using a tracer called PentixaFor) to see if it can help find which adrenal gland is making too much aldosterone in people with primary aldosteronism. The goal is to reduce the need for more invasive tests like adrenal vein sampling.
This study uses a new type of PET scan (called Gallium-68 Pentixafor PET-CT) to help doctors better identify the source of a hormone problem causing high blood pressure. The goal is to see if this scan leads to better surgical outcomes compared to standard methods.
Hear when a new Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.